// App-Quantinova.ai

191 : Adherence to a Treat-To-Target Strategy is Key to Attainment of Sustained Remission in Rheumatoid Arthritis: Data from the Real-world Practice BIODAM Cohort

Researchers

Presenter

  • Maggie Larche

Principal Investigators

  • Gilles Boire

  • Cheryl Barnabe

  • Proton Rahman

  • Carol Hitchon

  • Edna Hutchings

  • Rana Dadashova

  • Joel Paschke

  • Walter Maksymowych

Medical Centers

  • University of Alberta, Edmonton, AB, Canada

  • Univ of Calgary, Calgary, Canada

  • Univ of Manitoba, Winnipeg, Canada

  • McMaster University, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada

  • Universite de Sherbrooke, Sherbrooke, QC, Canada

  • Memorial University, St. John's, NF, Canada

Locations

  • Canada

Companies

  • CaRE Arthritis

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved